Limb Salvage and Prevention of Ulcer Recurrence in a Chronic Refractory Diabetic Foot Osteomyelitis

References

• Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293(2):217–228. doi:10.1001/jama.293.2.217
   PubMed Web of Science ®Google Scholar
• Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. New Engl J Med. 2017;376(24):2367–2375. doi:10.1056/NEJMra1615439
   PubMed Web of Science ®Google Scholar
• Mills JL Sr, Conte MS, Armstrong DG, et al. The society for vascular surgery lower extremity threatened limb classification system: risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg. 2014;59:220–34.e1–2. doi:10.1016/j.jvs.2013.08.003
   Google Scholar
• Takahara M, Iida O, Fujita Y, Haneda M. Clinical characteristics of Japanese diabetic patients with critical limb ischemia presenting Fontaine stage IV. Diabetol Int. 2018;10:231–235. doi:10.1007/s13340-018-0387-6
   PubMedGoogle Scholar
• Bakker K, Apelqvist J, Schaper NC. International Working Group on Diabetic Foot Editorial Board. Practical guidelines on the management and prevention of the diabetic foot 2011. Diabetes Metab Res Rev. 2012;28(Suppl 1):225–231. doi:10.1002/dmrr.2253
   PubMedGoogle Scholar
• Lazaro Martinez JL, Garcia Alvarez Y, Tardaguila-Garcia A, Garcia Morales E. Optimal management of diabetic foot osteomyelitis: challenges and solutions. Diabetes Metab Syndr Obes. 2019;12:947–959.
   PubMed Web of Science ®Google Scholar
• Johnson MJ, Shumway N, Bivins M, Bessesen MT. Outcomes of limb-sparing surgery for osteomyelitis in the diabetic foot: importance of the histopathologic margin. Open Forum Infect Dis. 2019;6(10):ofz382. doi:10.1093/ofid/ofz382
   PubMedGoogle Scholar
• Lissky BA, Senneville E, Abbas ZG, et al; on behalf of the International Working Group on the Diabetic Foot (IWGDF). IWGDF Guideline on the diagnosis and treatment of foot infection in persons with diabetes. Part of the 2019 IWGDF Guidelines on the prevention and management of diabetic foot disease. Available from: https://iwgdfguidelines.org/. Accessed June 15, 2020.
   Google Scholar
• Wukich DK, Hobizal KB, Sambenedetto TL, Kirby K, Rosario BL. Outcomes of osteomyelitis in patients hospitalized with diabetic foot infections. Foot Ankle Int. 2016;37(12):1285–1291. doi:10.1177/1071100716664364
   PubMedGoogle Scholar
• Deng W, Boey J, Chen B, et al. Platelet-rich plasma, bilayered acellular matrix grafting and negative pressure wound therapy in diabetic foot infection. J Wound Care. 2016;25(7):393–397. doi:10.12968/jowc.2016.25.7.393
   PubMedGoogle Scholar
• Ledoux WR, Shofer JB, Smith DG, et al. Relationship between foot type, foot deformity, and ulcer occurrence in the high-risk diabetic foot. J Rehabil Res Dev. 2005;42(5):665–671. doi:10.1682/JRRD.2004.11.0144
   PubMedGoogle Scholar
• Allan J, Munro W, Figgins E. Foot deformities within the diabetic foot and their influence on biomechanics: a review of the literature. Prosthet Orthot Int. 2016;40(2):182–192.
   PubMedGoogle Scholar
• Jeffcoate WJ, Harding KG. Diabetic foot ulcers. Lancet. 2003;361(9368):1545–1551. doi:10.1016/S0140-6736(03)13169-8
   PubMed Web of Science ®Google Scholar
• Fitzgerald RH, Vedpathak A. Plantar pressure distribution in a hyperpronatedfoot before and after intervention with an extraosseous talotarsalstabilization device-a retrospective study. J Foot Ankle Surg. 2013;52(4):432–443. doi:10.1053/j.jfas.2013.03.011
   PubMed Web of Science ®Google Scholar
• Andersen H. Motor dysfunction in diabetes. Diabetes-Metab Res. 2012;28:89–92. doi:10.1002/dmrr.2257
   PubMedGoogle Scholar
• Edwards J, Stapley S. Debridement of diabetic foot ulcers. Cochrane Database Syst Rev. 2010;1:CD003556.
   Google Scholar
• Dumville JC, O’Meara S, Deshpande S, Speak K. Hydrogel dressings for healing diabetic foot ulcers. Cochrane Database Syst Rev. 2013;7:CD009101.
   Google Scholar
• Aragon-Sanchez FJ, Cabrera-Galvan JJ, Quintana-Marrero Y, et al. Outcomes of surgical treatment of diabetic foot osteomyelitis: a series of 185 patients with histopathological confirmation of bone involvement. Diabetologia. 2008;51(11):1962–1970. doi:10.1007/s00125-008-1131-8
   PubMed Web of Science ®Google Scholar
• Senneville E, Robineau O. Treatment options for diabetic foot osteomyelitis. Expert Opin Pharmacother. 2017;18(8):759–765. doi:10.1080/14656566.2017.1316375
   PubMed Web of Science ®Google Scholar
• Mutluoglu M, Lipsky BA. Non-surgical treatment of diabetic foot osteomyelitis. Lancet Diabetes Endocrinol. 2017;5(8):668. doi:10.1016/S2213-8587(16)30141-3
   PubMed Web of Science ®Google Scholar
• Game F. Management of osteomyelitis of the foot in diabetes mellitus. Nat Rev Endocrinol. 2010;6(1):43–47. doi:10.1038/nrendo.2009.243
   PubMedGoogle Scholar
• Wahlig H, Dingeldein E, Bergmann R, Rruss K. The release of gentamicin from polymethylmethacrylate beads: an experimental and pharmacokinetic study. J Bone Joint Surg Br. 1979;60(2):270–275.
   Google Scholar
• Haydon RC, Blaha JD, Mancinelli C, Koike K. Audiometric thresholds in osteomyelitis patients treated with gentamicin-impregnated methylmethacrylate beads (Septopal). Clin Orthop Relat Res. 1993;295:43–46.
   Google Scholar
• Karr JC. Management in the wound-care center outpatient setting of a diabetic patient with forefoot osteomyelitis using Cerament Bone Void Filler impregnated with vancomycin: off-label use. J Am Podiatr Med Assoc. 2011;101(3):259–264. doi:10.7547/1010259
   PubMed Web of Science ®Google Scholar
• Martinez-Zapata MJ, Martí-Carvajal AJ, Solà I, et al. Autologous platelet-rich plasma for treating chronic wounds. Cochrane Database Syst Rev. 2016;5:CD006899.
   Google Scholar
• Li L, Chen D, Wang C, et al. Autologous platelet-rich gel for treatment of diabetic chronic refractory cutaneous ulcers: a prospective, randomized clinical trial. Wound Repair Regen. 2015;23(4):495–505. doi:10.1111/wrr.12294
   PubMedGoogle Scholar
• Ahmed M, Reffat SA, Hassan A, Eskander F. Platelet-rich plasma for the treatment of clean diabetic foot ulcers. Ann Vasc Surg. 2017;38:206–211. doi:10.1016/j.avsg.2016.04.023
   PubMed Web of Science ®Google Scholar
• Li T, Ma Y, Wang M, et al. Platelet-rich plasma plays an antibacterial, anti-inflammatory and cell proliferation-promoting role in an in vitro model for diabetic infected wounds. Infect Drug Resist. 2019;12:297–309. doi:10.2147/IDR.S186651
   PubMed Web of Science ®Google Scholar
• Zhang W, Guo Y, Kuss M, et al. Platelet-rich plasma for the treatment of tissue infection: preparation and clinical evaluation. Tissue Eng Part B Rev. 2019;25(3):225–236. doi:10.1089/ten.teb.2018.0309
   PubMed Web of Science ®Google Scholar
• Mariani E, Filardo G, Canella V, et al. Platelet-rich plasma affects bacterial growth in vitro. Cytotherapy. 2014;16(9):1294–1304. doi:10.1016/j.jcyt.2014.06.003
   PubMed Web of Science ®Google Scholar
• Borys S, Hohendorff J, Koblik T, et al. Negative-pressure wound therapy for management of chronic neuropathic noninfected diabetic foot ulcerations - short-term efficacy and long-term outcomes. Endocrine. 2018;62(3):611–616. doi:10.1007/s12020-018-1707-0
   PubMed Web of Science ®Google Scholar
• Wynn M, Freeman S. The efficacy of negative pressure wound therapy for diabetic foot ulcers: a systematised review. J Tissue Viability. 2019;28(3):152–160. doi:10.1016/j.jtv.2019.04.001
   PubMed Web of Science ®Google Scholar
• Abbott CA, Carrington AL, Ashe H, et al. The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med. 2002;19(5):377–384. doi:10.1046/j.1464-5491.2002.00698.x
   PubMed Web of Science ®Google Scholar
• Bus SA, Valk GD, van Deursen RW, et al. The effectiveness of footwear and offloading interventions to prevent and heal foot ulcers and reduce plantar pressure in diabetes: a systematic review. Diabetes Metab Res Rev. 2008;24(Suppl.1):S162–S180. doi:10.1002/dmrr.850
   PubMedGoogle Scholar
• Maciejewski ML, Reiber GE, Smith DG, Wallace C, Hayes S, Boyko EJ. Effectiveness of diabetic therapeutic footwear in preventing reulceration. Diabetes Care. 2004;27:1774–1782. doi:10.2337/diacare.27.7.1774
   PubMedGoogle Scholar
• Prompers L, Huijberts M, Apelqvist J, et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia. 2007;50(1):18–25. doi:10.1007/s00125-006-0491-1
   PubMed Web of Science ®Google Scholar
• Bus SA, Armstrong DG, Gooday C, et al; on behalf of the International Working Group on the Diabetic Foot (IWGDF). IWGDF Guideline on the offloading foot ulcers in persons with diabetes. Part of the 2019 IWGDF Guidelines on the prevention and management of diabetic foot disease. Available from: https://iwgdfguidelines.org/. Accessed June 15, 2020.
   Google Scholar